Kessler Foundation researchers have developed robust measures of neighborhood economic factors to study how social determinants influence health outcomes after spinal cord injury (SCI).
This designation supports the development of ExoPTEN and opens a pathway for faster entry into European markets, where the Company expects demand for effective spinal cord injury therapies to be high.